ArticleJournal for immunotherapy of cancer2022

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions.

Frank M Speetjens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.